Medical Pharmacology Chapter 33-34:  Anticancer Drugs

Previous Page Next Page
Section Table of Contents

Site Table of Contents

Previous Page Next Page
Section Table of Contents

Site Table of Contents

References
  1. Wellstein A Giaccone G Atkins MB Sausville Chapter 66:  Cytotoxic Drugs in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

  2. Sausville EA Longo DL Chapter 103e Principles of Cancer Treatment, in Harrison's Online   (Dennis L. Kasper, Anthony S. Fauci, Stephen L. Hauser, Dan L. Longo,  J. Larry Jameson, Joseph Loscalzo, Eds.),  Harrison's Principles of Internal Medicine, 19th edition, The McGraw-Hill Companies, Inc. 2015.

  3. Chu E  Cancer Chemotherapy Chapter 54 in Basic & Clinical Pharmacology, 14 e (Katzung BG The McGraw-Hill Companies, 2018 (on-line edition)

  4. Tew KD Chapter 17:  Alkylating Agents  in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  5. Collins JM Cancer Pharmacology Chapter 29 in Abeloff's Clinical Oncology (Niederhuber JE Armitage JO Doroshow JH Kastan MB Tepper JE, eds)  5e Elsevier Churchill Livingstone, Philadelphia, PA 2014.

  6. Saif MW Chu E Chapter 19 Antimetabolites in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 10e Wolters Kluwer Health 2015.

  7. Wellstein A Giaccone G Atkins MB Sausville Chapter 67:  Pathway-Targeted Therapies:  Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules in Goodman & Gilman's:  The Pharmacological Basis of Therapeutics, 13e, Brunton LL Hilal-Dandan R Knollmann BC, eds) 2018.

  8. Chau CH Figg WD Chabner BA Antimitiotic Drugs Chapter 11 in:  Cancer Chemotherapy, Immunotherapy and Biotherapy Principles and Practice Chabner BA Longo DL, eds 6e Wolters Kluwer 2019.

  9. Hoimes CJ Chapter 24: Antimicrotubule Agents in Principles & Practice of Oncology (DeVita, JR VT Lawrence TS Rosenberg SA, eds) 11e Wolters Kluwer Health 2018.

  10. Fransson MN Green H Litton J-E Friberg LE Influence of Cremophor EL and Genetic Polymorphisms on the Pharmacokinetics of Paclitaxel and its Metabolites Using a Mechanism-Based Model. Drug Metabolism and Disposition 39:  247-255, 2011.

  11. Ledermann J ICON8"  Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer.  VJOncology, published September 11, 2017. https://www.youtube.com/watch?v=cy4Qxn5xUiU

  12. G2 phase https://en.wikipedia.org/wiki/G2_phase#G2/M_checkpoint

  13. G2-M DNA damage checkpoint. https://en.wikipedia.org/wiki/G2-M_DNA_damage_checkpoint

  14. Rugo HS ASCO:  Newer Drugs No Better Than Paclitaxel. MDedge:  news and insights for busy physicians. Published on June 3, 2012. https://www.youtube.com/watch?v=nM7VHIjcWng

  15. Arndt C Neutropenia, Mayo Clinic. Published April 19, 2011. https://www.youtube.com/watch?v=elHk_fcANHs

  16. Wehler TC Cao Y Galle PR Moehler TM Schimanski CC Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-foot syndrome prophylaxis is performed continuously. Oncol Lett 2012 June 3(6) 1191-1194. https://www.ncbi.nlm.nih.gov/pubmed/22783416 https://www.researchgate.net/figure/Hand-foot-syndrome-HFS_fig1_229072765

  17. Breast Cancer Answers:  Hair Loss During Chemotherapy. Published April 25, 2014. https://www.youtube.com/watch?v=SZa-HsmpwCw

This Web-based pharmacology teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.  Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information.  Medical or other information  thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals.